• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . The morbidity spectrum of influenza, respiratory syncytial virus, human metapneumovirus and human parainfluenza virus in young ch

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2025 May 15:107938.
doi: 10.1016/j.ijid.2025.107938. Online ahead of print. The morbidity spectrum of influenza, respiratory syncytial virus, human metapneumovirus and human parainfluenza virus in young children by age and country income level: a systematic review and meta-analysis

Lian He[SUP] 1 [/SUP], Jitian Weng[SUP] 1 [/SUP], Fuyu Zhu[SUP] 1 [/SUP], Yuhe Zhang[SUP] 1 [/SUP], Junru Chen[SUP] 1 [/SUP], Shuting Chen[SUP] 1 [/SUP], Miaojia Lu[SUP] 1 [/SUP], Harish Nair[SUP] 2 [/SUP], You Li[SUP] 3 [/SUP], Xin Wang[SUP] 4 [/SUP]



Affiliations
Free article Abstract

Background: Influenza virus (IFV), respiratory syncytial virus (RSV), human metapneumovirus (hMPV) and parainfluenza virus (hPIV) cause substantial disease burden in children under 5 years, but the infection spectrum remains unclear.
Methods: We systematically reviewed studies published between 1995 and 2023 to estimate probabilities between viral test positivity, symptomatic infections, acute lower respiratory infections (ALRI), ALRI with chest-wall indrawing (CWI), ALRI hospitalisation, and very severe ALRI - p(symptomatic | test positive), p(ALRI | symptomatic), p(CWI | ALRI), p(hosp | ALRI) and p(very severe | hosp). (PROSPERO CRD42024584039; CRD42023439269).
Results: Based on 129 studies, we estimated that 67.7% of IFV test-positives were symptomatic and 16.2% of symptomatic IFV infections developed ALRI. In children under 2 years, 71.8% of RSV test-positives were symptomatic. Across the viruses, the estimated p(CWI | ALRI) and p(hosp | ALRI) were higher in infants than older children; between 2.6% and 41.2% of hospitalised children with ALRI were very severe, with higher estimates in low and lower-middle income countries.
Conclusions: Infants and children under 5 years in low and lower-middle income countries are important risk groups for immunisation due to their high vulnerability to severe outcomes. These findings provide critical data to support immunisation assessment and development of immunisation strategies.

Keywords: children; infection spectrum; influenza; metapneumovirus; parainfluenza virus; respiratory syncytial virus.

 
Back
Top Bottom